iShares MSCI Malaysia ETF vs FMC Corp — how do they compare? iShares MSCI Malaysia ETF trades at $26.66 (market cap $256.41M), while FMC Corp trades at $8.35 (market cap $1.39B). The key difference: FMC Corp is far larger — about 5.4× iShares MSCI Malaysia ETF's market cap, and FMC Corp pays a 3.59% dividend while iShares MSCI Malaysia ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Malaysia ETF for 66 Days and FMC Corp for 68 Days on average.
| EWM | FMC | |
|---|---|---|
Market Cap | $256.41M | $1.39B |
Volume | 111,962 | 4,145,979 |
Sector | Broad Market / Factor | Basic Materials |
52-Week High | $30.42 | $30.63 |
52-Week Low | $25.33 | $8.44 |
Typical Hold Time | 66 Days | 68 Days |
Enterprise Value | — | $5.19B |
Dividend Yield | — | 3.59% |
Signals from Pluang's Aura AI — not financial advice
EWM stock trades at $26.66 with minimal daily movement (+0.19%). Technical indicators show conflicting signals with moving averages suggesting bearish pressure while oscillators indicate potential oversold conditions. The stock faces immediate resistance at $27 and support at $26. Recent news highlights regional environmental challenges affecting operations.
The stock presents a cautious outlook with mixed technical signals and limited fundamental data available. Near-term direction will depend on earnings results and management guidance. Key risks include operational disruptions from regional environmental issues and broader market volatility affecting small-cap stocks.
FMC trades at $8.92, down 1.87% on the day, with a bearish technical outlook and mixed fundamentals. The stock shows weak profitability with a net income margin of -84.83% and negative ROE of -91.47% for 2025, though recent quarterly EPS beats offer some optimism. Analyst consensus is divided with a near-even split between Buy and Hold ratings, and a $14.60 price target suggests significant upside from current levels. Recent news highlights regulatory progress for rimisoxafen in Brazil and a minority equity investment from Tessenderlo Group.
The outlook for FMC hinges on successful deleveraging and product approvals, but high debt and cyclical industry pressures pose substantial risks. While valuation ratios like P/S of 0.34 appear attractive, persistent negative margins and volatile cash flows warrant caution. The stock presents a speculative opportunity for investors betting on a turnaround, but near-term headwinds in the agricultural sector may limit upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →